HIV/AIDS
Site Visit to Lyantonde: Life and Health Improve (2/2)
This is a guest post, written by Bob Leone, Lead, Outreach and Communications, Global Health Fellows Program II, a program led by the Public Health Institute. This is the second of two posts, you can find the first here. The elementary school students in Lyantonde, Uganda, some as young as seven or eight, are dressed…
Read MoreSite Visit to Lyantonde: East Africa Opens My Eyes (1/2)
This is a guest post, written by Bob Leone, Lead, Outreach and Communications, Global Health Fellows Program II, a program led by the Public Health Institute. This is the first of two posts. The streets funneling into the bus terminal in central Kampala churn and heave with activity: men congregate on corners talking and…
Read MoreThe Shirt You Couldn't Miss: Integrating HIV and GBV Prevention
Gender-based violence and a guide to assist with GBV and HIV prevention integration Ahh… ahh…Baby, I love you so much! …. We repeated this refrain, clapping the beat as the person in the middle of the circle selected his or her replacement. This activity broke the ice – but what happened next was more serious.…
Read MoreWorld AIDS Day 2011: Looking at a Year of Change
Andrew Fullem, JSI and World Ed director of HIV/AIDS reflects on the changes in the landscape of the disease World AIDS Day. It is that time of year again when attention focuses on the response to HIV, looking back at progress made and looking forward to the opportunities and challenges ahead. Much of the attention…
Read MoreMeeting Success, the Army Retreats: Cuts in Army Funding Threaten HIV Vaccine Progress
Sawe and Warren blog cuts to HIV vaccine development at DA threaten major new advances, future opportunities The Department of the Army is set to slash 73 percent of the U.S. Military HIV Research Program’s (MHRP) Army research budget for FY 13 through FY17. Incredibly, this cut comes on the heels of exciting and promising…
Read MoreJust Because You Build it Doesn't Mean They'll Come: Take Home Messaging From IAS
JSI’s Sharon Stash shares lessons learned from the International AIDS Society Conference in Rome Participants at last month’s International AIDS Society Conference in Rome were energized by positive findings on new biomedical HIV prevention interventions. Thirty years of dedicated work have resulted in the HPTN052 trial’s promise of HIV treatment as prevention and in positive…
Read MoreRe: IAS 2011 Examines Most-at-risk Populations: Commerical Sex Workers
This post is a response to the various comments received to the original post with the above title available here. I want to thank Cheryl Overs, Thierry Schaffauser and Calum Bennachie for their comments to my summary of the sessions I attended at IAS 2011 concerning sex workers. I am glad this point of police intervention has had…
Read MoreHormonal Birth Control Increases Women's Risk of HIV Acquisition and Transmission
A new study presented at the International AIDS Society Conference in Rome found that women who take hormonal contraceptives are at a greater risk of acquiring HIV and transmitting it to their male partners than women who do not take hormonal contraceptives. The study, conducted by the University of Washington, included 3790 serodiscordant couples from…
Read MoreIAS 2011 Examines Most-at-Risk Populations: Commerical Sex Workers
*Please note that this blog is a summary of sessions attended at the 2011 IAS and does not represent the views of the Council. The topic of most-at-risk populations (MARPs) was given healthy consideration at the 2011 IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome last week, particularly sex workers, injections drug users…
Read MoreTreatment as Prevention Implementation Challenges: More and Earlier HIV Testing
Last week at the International AIDS Society conference, researchers presented amazing new evidence proving the efficacy of treatment as prevention. The study, HPTN 052, showed a 96 percent reduction in sexual transmission of HIV between serodiscordant couples when the infected partner initiated antiretroviral therapy (ART) early. Conference delegates were overjoyed; years of research had finally…
Read More